Thursday, September 22, 2016

BRIEF-Aurobindo Pharma gets USFDA tentative approval for Dolutegravir

* Aurobindo Pharma receives USFDA tentative approval for

Dolutegravir, allowing the product to be launched in the PEPFAR

market

Source text: (http://bit.ly/2cTnfIs)

Further company coverage:

(Bengaluru newsroom)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)